Bleeding Complications in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Predictors, Prognostic Significance, and Paradigms for Reducing Risk

This publication has 25 references indexed in Scilit:

• Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes
  Journal of the American College of Cardiology, 2007
• Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
  The Lancet, 2007
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
  Circulation, 2006
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
  New England Journal of Medicine, 2006
• Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes
  JAMA, 2005
• The Implications of Blood Transfusions for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE National Quality Improvement Initiative
  Journal of the American College of Cardiology, 2005
• Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions
  The American Journal of Cardiology, 2003
• Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention
  American Journal of Health-System Pharmacy, 2003
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
  The Lancet, 1998
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997